Silent Strokes Linked to Kidney Failure in Patients With Diabetes
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Silent Strokes Linked to Kidney Failure in Patients With Diabetes

WASHINGTON, DC -- January 28, 2010 -- In patients with type 2 diabetes, silent cerebral infarction (SCI) signals an increased risk of progressive kidney disease and kidney failure, according to a study published early online and appearing in an upcoming issue of the Journal of the American Society Nephrology.

The results of the study suggest that if SCI is present in the brain, it could be an indicator that small-vessel damage is present in the kidneys as well.

“Silent cerebral infarction may be a new marker to identify patients who are risk for declining kidney function,” Takashi Uzu, MD, Shiga University School of Medicine, Otsu, Japan.

The study included 608 patients with type 2 diabetes, all initially free of symptomatic stroke, heart disease, or kidney disease (overt proteinuria or renal dysfunction). On magnetic resonance imaging (MRI) scans of the brain, 177 of the patients (29%) had SCI, but not severe enough to cause overt symptoms of stroke.

At long-term follow-up, diabetic patients with SCI had higher risks of progressive kidney disease. Compared with those with normal brain MRI scans, patients with SCI were about 2.5 times more likely to die or develop end-stage kidney disease. Their risk of declining kidney function or dialysis was nearly 5 times higher.

New approaches are needed to assess the risk of diabetes-related kidney disease.
“Microalbuminuria is the most important marker to predict the progression of kidney disease in diabetic patients,” said Dr. Uzu. “However, decreased kidney function without microalbuminuria is common in patients with type 2 diabetes.”

The study shows that patients with diabetes with subtle brain damage detected on MRI scans are more likely to develop serious kidney disease, independent of
microalbuminuria.

“Evaluating both SCI and microalbuminuria may be useful for determining the risk of progression of kidney disease in diabetic patients,” said Dr. Uzu.

The study had some risk of bias related to patient selection. Also, although most of the patients with SCI had multiple small areas of brain damage, the study did not exclude patients with relatively large areas of brain damage. “Therefore, not only small vessel disease but also relatively large vessel disease might have affected the progression of kidney disease in our patients,” added Dr. Uzu.

SOURCE: American Society of Nephrology

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities